Literature DB >> 8414034

Detection of hippocampal pathology in intractable partial epilepsy: increased sensitivity with quantitative magnetic resonance T2 relaxometry.

G D Jackson1, A Connelly, J S Duncan, R A Grünewald, D G Gadian.   

Abstract

Abnormal T2-weighted signal intensity in the hippocampus may be difficult to detect visually, and T2 mapping provides an objective means of assessing signal abnormality. We investigated 50 adult outpatients suffering from intractable partial epilepsy with MRI optimized to detect hippocampal and cortical gray matter abnormalities, and with MR T2 relaxation mapping. The range of normal hippocampal T2 relaxation times is small (99 to 106 msec), and the measurements are reproducible between observers. There were abnormal hippocampal T2 relaxation times in the hippocampus ipsilateral to the site of seizure origin in 70% of patients studied, with the more severe abnormality in the ipsilateral hippocampus in all cases. All hippocampal T2 measurements greater than 116 msec were associated with temporal lobe epilepsy and pathologic or MRI evidence of hippocampal sclerosis, or both. Bilateral abnormalities were present in 29% of cases with hippocampal sclerosis.

Entities:  

Mesh:

Year:  1993        PMID: 8414034     DOI: 10.1212/wnl.43.9.1793

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  65 in total

Review 1.  Update on surgery for epilepsy.

Authors:  J H Cross
Journal:  Arch Dis Child       Date:  1999-10       Impact factor: 3.791

2.  Increased anterior temporal lobe T2 times in cases of hippocampal sclerosis: a multi-echo T2 relaxometry study at 3 T.

Authors:  Regula S Briellmann; Ari Syngeniotis; Steve Fleming; Renate M Kalnins; David F Abbott; Graeme D Jackson
Journal:  AJNR Am J Neuroradiol       Date:  2004-03       Impact factor: 3.825

3.  In vivo MRI signatures of hippocampal subfield pathology in intractable epilepsy.

Authors:  Maged Goubran; Boris C Bernhardt; Diego Cantor-Rivera; Jonathan C Lau; Charlotte Blinston; Robert R Hammond; Sandrine de Ribaupierre; Jorge G Burneo; Seyed M Mirsattari; David A Steven; Andrew G Parrent; Andrea Bernasconi; Neda Bernasconi; Terry M Peters; Ali R Khan
Journal:  Hum Brain Mapp       Date:  2015-12-17       Impact factor: 5.038

4.  Brain imaging with synthetic MR in children: clinical quality assessment.

Authors:  Aaron M Betts; James L Leach; Blaise V Jones; Bin Zhang; Suraj Serai
Journal:  Neuroradiology       Date:  2016-07-20       Impact factor: 2.804

5.  Synthetic T2 mapping is correlated with time from stroke onset: a future tool in wake-up stroke management?

Authors:  Thomas Duchaussoy; Jean-François Budzik; Laurene Norberciak; Lucie Colas; Marta Pasquini; Sebastien Verclytte
Journal:  Eur Radiol       Date:  2019-05-28       Impact factor: 5.315

6.  Assessment of the preferred scout sagittal orientation for temporal lobe imaging with magnetic resonance.

Authors:  P M Gonçalves Pereira; E Oliveira; M F Secca
Journal:  MAGMA       Date:  2004-12-03       Impact factor: 2.310

7.  Abnormalities identified with T2 relaxometry in hippocampi remote from the seizure focus: do they mean anything?

Authors:  Andres M Kanner
Journal:  Epilepsy Curr       Date:  2004 May-Jun       Impact factor: 7.500

8.  Fast radio-frequency enforced steady state (FRESS) spin echo MRI for quantitative T2 mapping: minimizing the apparent repetition time (TR) dependence for fast T2 measurement.

Authors:  Jerry S Cheung; Enfeng Wang; XiaoAn Zhang; Emiri Mandeville; Eng H Lo; A Gregory Sorensen; Phillip Zhe Sun
Journal:  NMR Biomed       Date:  2011-07-14       Impact factor: 4.044

Review 9.  Mesial temporal lobe epilepsy: How do we improve surgical outcome?

Authors:  Maria Thom; Gary W Mathern; J Helen Cross; Edward H Bertram
Journal:  Ann Neurol       Date:  2010-10       Impact factor: 10.422

10.  A magnetic resonance study of complicated early childhood convulsion.

Authors:  R A Grünewald; T Farrow; P Vaughan; C D Rittey; J Mundy
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-11       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.